Skip to content

Contact +44 (0) 20 7060 7474 email us

Cardiovascular

Japanese Markets for Interventional Cardiology 2007

 

Publication Date June 2007
Publisher iData Research
Product Type Report
Pages 139
ISBN Number not applicable
Product Code IDR00053

Price

£4,950.00
approximately: $7,495 | €5,525

pdf

Buy Now

print £4,620 ($6,995 | €5,156)

Buy Now

Order above formats by FAX

Order by Fax

Summary

In 2006, the Japanese market for interventional cardiology increased at almost 2% over 2005. This market is comprised of coronary stents, PTCA balloons, IVUS catheters, interventional catheters, interventional guidewires, introducer sheaths, embolic protection devices (EPD), thrombectomy devices, and diagnostic catheters, as shown in Chart 1-1. Japan has one of the oldest populations in the world, and demographic pressure is increasing the demand for healthcare. As a result, the Japanese government is attempting to decrease costs by reducing reimbursement rates, thus limiting the market for interventional cardiology devices.

Contents

  • LIST OF FIGURES
  • LIST OF CHARTS
  • EXECUTIVE SUMMARY
    • 1.1 JAPANESE MARKET FOR INTERVENTIONAL CARDIOLOGY DECES
    • 1.2 BARE-METAL AND DRUG-ELUTING
    • 1.3 PTCA BALLOONS
    • 1.4 IVUS CATHETERS
    • 1.5 INTERVENTIONAL CATHETERS
    • 1.6 INTERVENTIONAL GUIDEWIRES
    • 1.7 INTRODUCER SHEATHS
    • 1.8 DIAGNOSTIC CORONARY CATHETERS
    • 1.9 EMBOLIC PROTECTION DECES
    • 1.10 THROMBECTOMY DECES
    • 1.11 POTENTIAL MARKETS
    • 1.12 COMPETITIVE ANALYSIS
  • RESEARCH METHODOLOGY
    • 2.1 RESEARCH SCOPE
    • 2.2 IDATA'S 9 STEP METHODOLOGY
    • 2.2.1 Step 1: Project Initiation & Team Selection
    • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
    • 2.2.3 Step 3: Preparation for Interews & Survey design
    • 2.2.4 Step 4: Performing Primary Research
    • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
    • 2.2.6 Step 6: Market Forecasting
    • 2.2.7 Step 7: Identify Strategic Opportunities
    • 2.2.8 Step 8: Final Reew and Market Release
    • 2.2.9 Step 9: Customer Feedback and Market Monitoring
  • JAPANESE MARKET FOR INTERVENTIONAL CARDIOLOGY DECES
    • 3.1 INTRODUCTION
    • 3.2 EXCHANGE RATES
    • 3.3 OVEREW OF THE MARKET
    • 3.4 TREND ANALYSIS BY MARKET SEGMENT
    • 3.5 MARKET DRIVERS
    • 3.6 MARKET LIMITERS
    • 3.7 COMPETITIVE ANALYSIS
    • 3.8 MARKET CONCENTRATION
    • 3.9 MERGERS AND ACQUISITIONS
    • 3.9.1 Boston Scientific Acquires Guidant
    • 3.9.2 Abbott Laboratories Acquires Guidant's Interventional Cardiology Dision
    • 3.9.3 Johnson & Johnson Agrees to Acquire Conor Medsystems
    • 3.9.4 Future Acquisitions
    • 3.10 LITIGATION ISSUES
    • 3.11 POTENTIAL MARKETS
    • BARE-METAL AND DRUG-ELUTING
    • 4.1 INTRODUCTION
    • 4.2 PROCEDURE NUMBERS
    • 4.3 MARKET ANALYSIS AND FORECAST
    • 4.4 STENT MARKET BY SIZE
    • 4.5 BARE-METAL STENT MARKET
    • 4.5.1 Market Analysis and Forecast
    • 4.6 COMPETITIVE ANALYSIS
    • 4.7 DRUG-ELUTING STENT MARKET
    • 4.7.1 Market Analysis and Forecast
    • 4.8 COMPETITIVE ANALYSIS
    • 4.9 MARKET DRIVERS AND LIMITERS
    • 4.9.1 Market Drers
    • 4.9.2 Market Limiters
    • 4.10 NEW MARKET PARTICIPANTS
    • 4.10.1 Boston Scientific
    • 4.10.2 Abbott Laboratories
    • 4.10.3 Medtronic
    • 4.10.4 Conor Medsystems
    • 4.10.5 B. Braun
    • 4.10.6 Competite Landscape
  • PTCA BALLOON CATHETERS
    • 5.1 INTRODUCTION
    • 5.2 MARKET ANALYSIS AND FORECAST
    • 5.3 DIRECT STENTING
    • 5.4 MARKET DRIVERS AND LIMITERS
    • 5.4.1 Market Drers
    • 5.4.2 Market Limiters
    • 5.5 COMPETITIVE ANALYSIS
  • IVUS CATHETERS
    • 6.1 INTRODUCTION
    • 6.2 MARKET ANALYSIS AND FORECAST
    • 6.3 MARKET DRIVERS AND LIMITERS
    • 6.3.1 Market Drers
    • 6.3.2 Market Limiters
    • 6.4 COMPETITIVE ANALYSIS
  • INTERVENTIONAL CATHETERS
    • 7.1 INTRODUCTION
    • 7.2 MARKET ANALYSIS AND FORECAST
    • 7.3 MARKET DRIVERS AND LIMITERS
    • 7.3.1 Market Drers
    • 7.3.2 Market Limiters
    • 7.4 COMPETITIVE ANALYSIS
  • INTERVENTIONAL GUIDEWIRES
    • 8.1 INTRODUCTION
    • 8.2 MARKET ANALYSIS AND FORECAST
    • 8.3 CONVENTIONAL GUIDEWIRE MARKET
    • 8.4 SPECIALIZED GUIDEWIRE MARKET
    • 8.5 MARKET DRIVER AND LIMITERS
    • 8.5.1 Market Drers
    • 8.5.2 Market Limiters
    • 8.6 COMPETITIVE ANALYSIS
  • EMBOLIC PROTECTION DECES
    • 9.1 INTRODUCTION
    • 9.2 MARKET ANALYSIS AND FORECAST
    • 9.3 MARKET DRIVERS AND LIMITERS
    • 9.3.1 Market Drers
    • 9.3.2 Market Limiters
    • 9.4 COMPETITIVE ANALYSIS
  • THROMBECTOMY DECES
    • 10.1 INTRODUCTION
    • 10.1.1 Thrombosis in Japanese Patients
    • 10.2 MARKET ANALYSIS AND FORECAST
    • 10.3 MARKET DRIVERS AND LIMITERS
    • 10.3.1 Market Drers
    • 10.3.2 Market Limiters
    • 10.4 COMPETITIVE ANALYSIS
  • INTRODUCER SHEATHS
    • 11.1 INTRODUCTION
    • 11.2 MARKET ANALYSIS AND FORECAST
    • 11.3 FEMORAL MARKET
    • 11.4 TRANSRADIAL/BRACHIAL MARKET
    • 11.5 MARKET DRIVERS AND LIMITERS
    • 11.5.1 Market Drers
    • 11.5.2 Market Limiters
    • 11.6 COMPETITIVE ANALYSIS
  • DIAGNOSTIC CATHETERS
    • 12.1 INTRODUCTION
    • 12.2 MARKET ANALYSIS AND FORECAST
    • 12.3 UNITS SOLD SEGMENTED BY SIZE
    • 12.4 MARKET DRIVERS AND LIMITERS
    • 12.4.1 Market Drers
    • 12.4.2 Market Limiters
    • 12.5 COMPETITIVE ANALYSIS
  • VULNERABLE PLAQUE DECES
    • 13.1 INTRODUCTION
    • 13.2 TARGET POPULATION
    • 13.3 POTENTIAL MARKET: BEST-CASE SCENARIO
    • 13.4 SCREENING MARKET
    • 13.4.1 Market Analysis and Forecast: Best-Case Scenario
    • 13.5 INTERVENTIONAL MARKET
    • 13.5.1 Market Analysis and Forecast: Best-Case Scenario
    • 13.5.2 Revenue Probability
    • 13.6 COMPETITIVE ANALYSIS
    • 13.6.1 Lightlab
    • 13.6.2 InfraRedX
    • 13.6.3 Volcano Therapeutics
    • 13.6.4 Bristol-Myers Squibb
    • 13.6.5 Medeikon
    • 13.6.6 Cryocath
    • 13.6.7 Miravant Technologies
    • 13.6.8 Boston Scientific
    • 13.6.9 Abbott Laboratories
    • 13.6.10 Cordis
    • 13.6.11 Medtronic
  • ABBREATIONS
  • LIST OF FIGURES
    • Figure 1-1 IVUS Market Drers and Limiters, 2006
    • Figure 3-1 Japanese Market for Interventional Cardiology Segmented by Dece Type,2003 2013 (US$)
    • Figure 3-2 Japanese Market for Interventional Cardiology Segmented by Dece Type,2003 2013 ()
    • Figure 3-3 Trend Analysis by Market Segment, Growth Rates of the Japanese Market for Interventional Cardiology, 2003 2013
    • Figure 3-4 Market Drers, Japanese Market for Interventional Cardiology, 2006
    • Figure 3-5 Market Limiters, Japanese Market for Interventional Cardiology, 2006
    • Figure 3-6 Leading Competitors by Market Segment, Japanese Market for Interventional Cardiology, 2006
    • Figure 3-7 Market Concentration based on the Herfindahl Index, Japanese Market for Interventional Cardiology, 2003 2013
    • Figure 4-1 Angiography and Angioplasty Procedures in Japan, 2003 2013
    • Figure 4-2 Japanese Market for Coronary Stents by Type, 2003 2013 (US$)
    • Figure 4-3 Japanese Market for Coronary Stents by Type, 2003 2013 ()
    • Figure 4-4 Japanese Market for Coronary Stents by Size, Units Sold, 2006
    • Figure 4-5 Japanese Market for Bare-Metal Stents, 2003 2013 (US$)
    • Figure 4-6 Japanese Market for Bare-Metal Stents, 2003 2013 ()
    • Figure 4-7 Leading Competitors, Japanese Market for Bare-Metal Stents, 2006
    • Figure 4-8 Japanese Market for Drug-Eluting Stents, 2003 2013 (US$)
    • Figure 4-9 Japanese Market for Drug-Eluting Stents, 2003 2013 ()
    • Figure 4-10 Leading Competitors, Japanese Market for Drug-Eluting Stents, 2006
    • Figure 4-11 Market Drers, Japanese Market for Coronary Stents, 2006
    • Figure 4-12 Market Limiters, Japanese Market for Coronary Stents, 2006
    • Figure 4-13 New Market Participants, Japanese DES Market, 2006
    • Figure 5-1 Units Sold, Japanese Market for PTCA Balloon Catheters, 2003 2013
    • Figure 5-2 Japanese Market for PTCA Balloon Catheters, 2003 2013 (US$)
    • Figure 5-3 Japanese Market for PTCA Balloon Catheters, 2003 2013 ()
    • Figure 5-4 Market Drers and Limiters, Japanese Market for PTCA Balloon Catheters, 2006
    • Figure 5-5 Leading Competitors, Japanese Market for PTCA Balloon Catheters, 2006
    • Figure 6-1 Penetration Rate, Japanese Market for IVUS Catheters, 2003 2013
    • Figure 6-2 Japanese Market for IVUS Catheters, 2003 2013 (US$)
    • Figure 6-3 Japanese Market for IVUS Catheters, 2003 2013 ()
    • Figure 6-4 Market Drers and Limiters, Japanese Market for IVUS Catheters, 2003 2013
    • Figure 6-5 Leading Competitors, Japanese Market for IVUS Catheters, 2003 2013
    • Figure 7-1 Units Sold, Japanese Market for Interventional Catheters, 2003 2013
    • Figure 7-2 Japanese Market for Interventional Catheters, 2003 2013 (US$)
    • Figure 7-3 Japanese Market for Interventional Catheters, 2003 2013 ()
    • Figure 7-4 Market Drers and Limiters, Japanese Market for Interventional Catheters,2006
    • Figure 7-5 Leading Competitors, Japanese Market for Interventional Catheters, 2006
    • Figure 8-1 Units Sold, Japanese Market for Interventional Guidewires, 2003 2013
    • Figure 8-2 Japanese Market for Interventional Guidewires by Dece Type, 2003 2013 (US$)
    • Figure 8-3 Japanese Market for Interventional Guidewires by Dece Type, 2003 2013 ()
    • Figure 8-4 Japanese Market for Interventional Conventional Guidewires, 2003 2013(US$)
    • Figure 8-5 Japanese Market for Interventional Conventional Guidewires, 2003 2013()
    • Figure 8-6 Japanese Market for Interventional Specialized Guidewires, 2003 2013(US$)
    • Figure 8-7 Japanese Market for Interventional Specialized Guidewires, 2003 2013()
    • Figure 8-8 Market Drers and Limiters, Japanese Market for Interventional Guidewires, 2006
    • Figure 8-9 Leading Competitors, Japanese Market for Interventional Guidewires, 2006
    • Figure 9-1 Units Sold, Japanese Market for Embolic Protection Deces, 2003 2013
    • Figure 9-2 Japanese Market for Embolic Protection Deces, 2003 2013 (US$)
    • Figure 9-3 Japanese Market for Embolic Protection Deces, 2003 2013 ()
    • Figure 9-4 Market Drers and Limiters, Japanese Market for Embolic Protection Deces, 2006
    • Figure 9-5 Leading Competitors, Japanese Market for Embolic Protection Deces,2006
    • Figure 10-1 Units Sold, Japanese Market for Thrombectomy Deces, 2003 2013
    • Figure 10-2 Japanese Market for Thrombectomy Deces, 2003 2013 (US$)
    • Figure 10-3 Japanese Market for Thrombectomy Deces, 2003 2013 ()
    • Figure 10-4 Market Drers and Limiters, Japanese Market for Thrombectomy Deces, 2006
    • Figure 10-5 Leading Competitors, Japanese Market for Thrombectomy Deces, 2006
    • Figure 11-1 Units Sold, Japanese Market for Introducer Sheaths, 2003 2013
    • Figure 11-2 Japanese Market for Introducer Sheaths by Application, 2003 2013(US$)
    • Figure 11-3 Japanese Market for Introducer Sheaths by Application, 2003 2013 ()
    • Figure 11-4 Japanese Market for Femoral Introducer Sheaths, 2003 2013 (US$)
    • Figure 11-5 Japanese Market for Femoral Introducer Sheaths, 2003 2013
    • Figure 11-6 Japanese Market for Transradial/Brachial Introducer Sheaths, 2003 2013(US$)
    • Figure 11-7 Japanese Market for Transradial/Brachial Introducer Sheaths, 2003 2013
    • Figure 11-8 Market Drers and Limiters, Japanese Market for Introducer Sheaths,2006
    • Figure 11-9 Leading Competitors, Japanese Market for Introducer Sheaths, 2006
    • Figure 12-1 Units Sold, Japanese Market for Diagnostic Catheters, 2003 2013
    • Figure 12-2 Japanese Market for Diagnostic Catheters, 2003 2013 (US$)
    • Figure 12-3 Japanese Market for Diagnostic Catheters, 2003 2013 ()
    • Figure 12-4 Units Sold Segmented by Size, Japanese Market for Diagnostic Catheters,2003 2013
    • Figure 12-5 Market Drers and Limiters, Japanese Market for Diagnostic Catheters,2006
    • Figure 12-6 Leading Competitors, Japanese Market for Diagnostic Catheters, 2006
    • Figure 13-1 Target Population, Potential Japanese Market for Vulnerable Plaque, 2009 2013
    • Figure 13-2 Potential Japanese Market for Vulnerable Plaque, Best-Case Scenario,2009 2013 (US$)
    • Figure 13-3 Potential Japanese Market for Vulnerable Plaque, Best-Case Scenario,2009 2013 ()
    • Figure 13-4 Potential Japanese Market for Vulnerable Plaque Screening Deces, Best- Case Scenario, 2009 2013 (US$M)
    • Figure 13-5 Total Revenue, Potential Japanese Market for Vulnerable Plaque Screening Deces, Best-Case Scenario, 2009 2013 (US$M)
    • Figure 13-6 Potential Japanese Market for Vulnerable Plaque Screening Deces, Best- Case Scenario, 2009 2013 ()
    • Figure 13-7 Total Revenue, Potential Japanese Market for Vulnerable Plaque Screening Deces, Best-Case Scenario, 2009 2013 ()
    • Figure 13-8 Potential Japanese Market for Vulnerable Plaque Interventional Deces, Best-Case Scenario, 2009 2013 (US$)
    • Figure 13-9 Total Revenue, Potential Japanese Market for Vulnerable Plaque Interventional Deces, Best-Case Scenario, 2009 2013 (US$)
    • Figure 13-10 Potential Japanese Market for Vulnerable Plaque Interventional Deces, Best-Case Scenario, 2009 2013 ()
    • Figure 13-11 Total Revenue, Potential Japanese Market for Vulnerable Plaque Interventional Deces, Best-Case Scenario, 2009 2013 ()
    • Figure 13-12 Market Players, Potential Japanese Market for Vulnerable Plaque Deces, 2009 2013
  • LIST OF CHARTS
    • Chart 1-1 Japanese Market for Interventional Cardiolgy by Segment, 2006
    • Chart 1-2 Japanese Market for Coronary Stents, 2003 2013 (US$)
    • Chart 1-3 Japanese Market for PTCA Balloons, 2003 2013 (US$)
    • Chart 1-4 Japanese Market for Interventional Catheters, 2003 2013 (US$)
    • Chart 1-5 Specialized Guidewire Penetration Rate, 2006
    • Chart 1-6 Japanese Market for Introducer Sheaths, 2003 2013 (US$)
    • Chart 1-7 Units Sold Segmented by Size, Japanese Market for Diagnostic Coronary Catheters, 2003 2013
    • Chart 1-8 Leading Competitors, Japanese Market for Interventional Cardiology, 2006
    • Chart 3-1 Exchange Rate between the U.S. Dollar (US$) and the Yen (), 2006
    • Chart 3-2 Japanese Market for Interventional Cardiology, 2003 2013 (US$)
    • Chart 3-3 Japanese Market for Interventional Cardiology Segmented by Dece Type,2006
    • Chart 3-4 Trend Analysis by Market Segment, Japanese Market for Interventional Cardiology, 2003 2013
    • Chart 3-5 Leading Competitors, Japanese Market for Interventional Cardiology, 2006
    • Chart 3-6 Market Concentration based on the Herfindahl Index, Japanese Market for Interventional Cardiology, 2003 2013
    • Chart 4-1 Angioplasty and Angiography Procedures in Japan, 2003 2013
    • Chart 4-2 Japanese Market for Coronary Stents by Type, 2003 2013 (US$)
    • Chart 4-3 Japanese Market for Coronary Stents by Size, Units Sold, 2006
    • Chart 4-4 BMS Penetration Rate in Japan, 2003 2013
    • Chart 4-5 Japanese Market for Bare-Metal Stents, 2003 2013 (US$)
    • Chart 4-6 DES Penetration Rate in Japan, 2003 2013
    • Chart 4-7 Japanese Market for Drug-Eluting Stents, 2003 2013 (US$)
    • Chart 5-1 Japanese Market for PTCA Balloon Catheters, 2003 2013 (US$)
    • Chart 5-2 Direct-Stenting Penetration, Japanse Market for PTCA Balloons, 2003 2013
    • Chart 6-1 Japanese Market for IVUS Catheters, 2003 2013 (US$)
    • Chart 7-1 Japanese Market for Interventional Catheters, 2003 2013 (US$)
    • Chart 8-1 Japanese Market for Interventional Guidewires by Dece Type, 2003 2013(US$)
    • Chart 8-2 Conventional Guidewire Penetration Rate, 2006
    • Chart 8-3 Specizlized Guidewire Penetration Rate, 2006
    • Chart 9-1 Japanese Market for Embolic Protection Deces, 2003 2013 (US$)
    • Chart 10-1 Japanese Market for Thrombectomy Deces, 2003 2013 (US$)
    • Chart 11-1 Japanese Market for Introducer Sheaths by Application, 2003 2013 (US$)
    • Chart 11-2 Femoral Application, Penetration Rate, 2003 2013
    • Chart 11-3 Transradial/Brachial Application, Penetration Rate, 2003 2013
    • Chart 12-1 Japanese Market for Diagnostic Catheters, 2003 2013 (US$)
    • Chart 12-2 Units Sold Segmented by Size, Japanese Market for Diagnostic Catheters,2003 2013 (US$)
    • Chart 13-1 Potential Japanese Market for Vulnerable Plaque, Best-Case Scenario, 2009 2013 (US$)
    • Chart 13-2 Revenue Probability, Potential Japanese Market for Vulnerable Plaque, 2009 2013 (US$)
Product Features / Use
Scope Comprehensive Overview
Data Detailed Market Forecasts
Profiles Profiles of Key Companies
Features Primary Research Data